Skip to main content Help with accessibility Skip to main navigation

Evolocumab

Indication

Prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin
Evolocumab for NICE TA394
Black

Brand:

Repatha®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Cardiovascular system

Background

The evidence for Evolocumab in the setting of patients with CHD and a history of ACS, in combination with a statin was reviewed however this did not provide adequate cost effectiveness data to allow use in patients in addition to those covered by NICE TA394

Recommendation

LSCMMG Recommendation:

Black

Reason for decision:

Not recommended for prescribing on the NHS in Lancashire & South Cumbria

Decisions of Lancashire local decision making groups

Black
Black
Black
Black
Black
Black
Black
Black
What do the colours mean?

Last Updated: 01 - Jul - 2018